Reconsidering the Diagnosis: Abnormal Sweat Chloride Tests in Non‐CF Bronchiectasis
Pediatric Pulmonology · 2025
DOI: 10.1002/ppul.27471 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Pulmonology, 2025. Verfasst von Reyna L Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Virginia, Charlottesville, Virginia, USA. Hauptthemen laut MEDLINE: Sweat, Chlorides, Cystic Fibrosis Transmembrane Conductance Regulator, Cystic Fibrosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Introduction
While the diagnosis of cystic fibrosis (CF) is often straightforward and reliant on correlation between genetic testing and clinical signs and symptoms, there is a subset where the distinction is not nearly as clearcut. This has previously been reported in patients identified through newborn screening but not meeting full CF diagnostic criteria, earning the label of CF Screen Positive, Inconclusive Diagnosis (CFSPID) instead. A homologous diagnostic category in adults is named CF Transmembrane Conductance Regulator‐Related Disorder (CFTR‐RD).
Methods
Through a retrospective chart review, this study reports on a relatively large adult cohort ( n = 23) that presented to pulmonology clinic at a single center with intermediate or positive sweat chloride tests but non‐diagnostic full CFTR gene analysis.
Results
Median sweat chloride result was 48 mmol/L, and a majority of the cohort had chronic lung disease with atypical pathogens on sputum culture, including Pseudomonas aeruginosa, non‐tuberculous Mycobacteria, Acinetobacter species, amongst others.
Conclusions
This clinical picture suggests CFTR dysfunction or similar mechanism in the absence of an identified genetic cause. Alternate chloride channels and their respective genes or candidates of genetic modifiers to the CF‐phenotype could be targets of further research in this cohort or similar patients. Such genetic modifiers include loci that have been implicated in inflammation, the CFTR interactome, and/or co‐/post‐translational modification of CFTR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Medicine, University of Virginia, Charlottesville, Virginia, USA.
- Department of Pediatrics, Division of Genetics, University of Virginia, Charlottesville, Virginia, USA.
- College of Arts and Sciences, University of Virginia, Charlottesville, Virginia, USA.
- Department of Internal Medicine, Division of Pulmonary and Critical Care, University of Virginia, Charlottesville, Virginia, USA.
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Huang, R. L., Snyder, M. T., Fahmida, N., & Albon, D. P. (2025). Reconsidering the Diagnosis: Abnormal Sweat Chloride Tests in Non‐CF Bronchiectasis. Pediatric Pulmonology. https://doi.org/10.1002/ppul.27471
Vancouver
Huang RL, Snyder MT, Fahmida N, Albon DP. Reconsidering the Diagnosis: Abnormal Sweat Chloride Tests in Non‐CF Bronchiectasis. Pediatric Pulmonology. 2025. doi:10.1002/ppul.27471
BibTeX
@article{Huang2025,
author = {Huang, Reyna L and Snyder, Matthew T and Fahmida, Nuzhat and Albon, Dana P},
title = {Reconsidering the Diagnosis: Abnormal Sweat Chloride Tests in Non‐CF Bronchiectasis},
journal = {Pediatric Pulmonology},
year = {2025},
doi = {10.1002/ppul.27471}
}
EUVIMED